These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 565169)

  • 21. Clinical heparin coated cardiopulmonary bypass: reduction of systemic heparin requirements for redo cardiac surgery.
    Ladowski JS; Schatzlein MH; Peterson AC; Deschner WP; Matheis R; Ellenwood M; Bach J; Moldovan L; McKamey D
    ASAIO J; 1996; 42(1):34-6. PubMed ID: 8808455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of endobronchial hemorrhage during cardiopulmonary bypass.
    Rice PL; Pifarré R; El-Etr A; Loeb H; Istanbouli M
    J Thorac Cardiovasc Surg; 1981 May; 81(5):800-1. PubMed ID: 7218848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation disorders of cardiopulmonary bypass: a review.
    Paparella D; Brister SJ; Buchanan MR
    Intensive Care Med; 2004 Oct; 30(10):1873-81. PubMed ID: 15278267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
    Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
    Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructure of human myocardium after total cardiopulmonary bypass during open-heart surgery.
    Schaper J; Hehrlein F; Thiedemann KU; Schlipper M
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():399-404. PubMed ID: 1197891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effects of the heparin coated surface in cardiopulmonary bypass.
    Svenmarker S; Sandström E; Karlsson T; Jansson E; Häggmark S; Lindholm R; Appelblad M; Aberg T
    Eur J Cardiothorac Surg; 1997 May; 11(5):957-64. PubMed ID: 9196315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
    Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
    Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Massive endobronchial hemorrhage during cardiopulmonary bypass: treatable complication of balloon-tipped catheter damage to the pulmonary artery.
    Cervenko FW; Shelley SE; Spence DG; Charrette EJ; Salerno TA
    Ann Thorac Surg; 1983 Mar; 35(3):326-8. PubMed ID: 6830370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of cardiopulmonary bypass during cardiac surgery for patients with heparin-induced thrombocytopenia].
    Kondo T; Hirota M; Hoshino J; Fukada Y; Isomura T
    Kyobu Geka; 2013 May; 66(5):366-9. PubMed ID: 23674032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery.
    Bosch YP; Al Dieri R; ten Cate H; Nelemans PJ; Bloemen S; de Laat B; Hemker C; Weerwind PW; Maessen JG; Mochtar B
    Thromb Res; 2014 Mar; 133(3):488-94. PubMed ID: 24388571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
    Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
    Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.
    Gu YJ; van Oeveren W; Akkerman C; Boonstra PW; Huyzen RJ; Wildevuur CR
    Ann Thorac Surg; 1993 Apr; 55(4):917-22. PubMed ID: 8466349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of myocardial damage during cardiac operations.
    Kirklin JW; Conti VR; Blackstone EH
    N Engl J Med; 1979 Jul; 301(3):135-41. PubMed ID: 377074
    [No Abstract]   [Full Text] [Related]  

  • 38. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State-of-the-art surgical coronary revascularization: Multiple arterial conduits, minimal aortic manipulation.
    Yanagawa B; Puskas JD
    J Thorac Cardiovasc Surg; 2015 Jul; 150(1):259-61. PubMed ID: 26126471
    [No Abstract]   [Full Text] [Related]  

  • 40. The hemostatic defect of cardiopulmonary bypass.
    Linden MD
    J Thromb Thrombolysis; 2003 Dec; 16(3):129-47. PubMed ID: 15087599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.